Sialorrhea - 18 Studies Found

Completed : Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)
:
  • Amyotrophic Lateral Sclerosis
  • Sialorrhea

: 2005-07-27
:
  • Drug: Botulinum toxin type B (Myobloc)
  • Pro
Completed : Metoclopramide as Treatment of Clozapine-induced Hypersalivation
: Clozapine-induced Hypersalivation
: 2014-08-17
:
  • Drug: Metoclopramide 30 mg/day
Completed : Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
: Clozapine-induced Hypersalivation
: 2007-09-24
: Drug: Amisulpride, Moclobemide Amisulpride 400 mg/d; Moclobemide 300 mg/d every medication for 2 week ai
Completed : A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients
: Drooling
: 2007-08-10
:
  • Biological: Botulinum Toxin Type B (Myobloc)
Completed : Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions
:
  • Chronic Troublesome Sialorrhea
  • Parkinson's Disease
  • : 2014-03-18
    :
    • Drug: IncobotulinumtoxinA (100 Units)

Completed : The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia
:
  • Schizophrenia
  • Clozapine
  • Hypersalivat
    : 2010-01-05
    :
    • Drug: Suo Quan Wan, Wu Lin San

Completed : FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey
:
  • Weight Gain
  • Sialorrhea

: 2008-05-22
: Drug: FazaClo (clozapine, USP) ODT
Completed : Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy
:
  • Sialorrhea
  • Cerebral Palsy

: 2011-11-29
: Biological: BOTULINUM NEUROTOXIN TYPE-A Botulinum toxin type A / First infiltration: 25U in each salivar
<<< Previous